David R. Gibb, Ph.D. - Publications

Affiliations: 
2012 Microbiology & Immunology Virginia Commonwealth University, Richmond, VA, United States 

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Escamilla-Rivera V, Santhanakrishnan M, Liu J, Gibb DR, Forsmo JE, Foxman EF, Eisenbarth SC, Luckey CJ, Zimring JC, Hudson KE, Stowell SR, Hendrickson JE. Complement Plays a Critical Role in Inflammation-Induced Immunoprophylaxis Failure in Mice. Frontiers in Immunology. 12: 704072. PMID 34249009 DOI: 10.3389/fimmu.2021.704072  0.332
2018 Patel SR, Gibb DR, Girard-Pierce K, Zhou X, Rodrigues LC, Arthur CM, Bennett AL, Jajosky RP, Fuller M, Maier CL, Zerra PE, Chonat S, Smith NH, Tormey CA, Hendrickson JE, et al. Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion. Frontiers in Immunology. 9: 2516. PMID 30505302 DOI: 10.3389/Fimmu.2018.02516  0.392
2018 Madrid D, Gibb D, Natarajan P, Santhanakrishnan M, Liu J, Hendrickson J. 3 The Importance of CD4 Cells and CD40/CD40 Ligand Interactions in Humoral Immune Responses to Transfused KEL RBCs in Mice American Journal of Clinical Pathology. 149: S164-S164. DOI: 10.1093/AJCP/AQX149.372  0.338
2017 Natarajan P, Liu D, Patel SR, Santhanakrishnan M, Beitler D, Liu J, Gibb DR, Liepkalns JS, Madrid DJ, Eisenbarth SC, Stowell SR, Hendrickson JE. CD4 Depletion or CD40L Blockade Results in Antigen-Specific Tolerance in a Red Blood Cell Alloimmunization Model. Frontiers in Immunology. 8: 907. PMID 28824633 DOI: 10.3389/Fimmu.2017.00907  0.3
2012 Saleem SJ, Martin RK, Morales JK, Sturgill JL, Gibb DR, Graham L, Bear HD, Manjili MH, Ryan JJ, Conrad DH. Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. Journal of Immunology (Baltimore, Md. : 1950). 189: 511-5. PMID 22706087 DOI: 10.4049/Jimmunol.1200647  0.708
2011 Chaimowitz NS, Martin RK, Cichy J, Gibb DR, Patil P, Kang DJ, Farnsworth J, Butcher EC, McCright B, Conrad DH. A disintegrin and metalloproteinase 10 regulates antibody production and maintenance of lymphoid architecture. Journal of Immunology (Baltimore, Md. : 1950). 187: 5114-22. PMID 21998451 DOI: 10.4049/Jimmunol.1102172  0.785
2011 Mathews JA, Ford J, Norton S, Kang D, Dellinger A, Gibb DR, Ford AQ, Massay H, Kepley CL, Scherle P, Keegan AD, Conrad DH. A potential new target for asthma therapy: a disintegrin and metalloprotease 10 (ADAM10) involvement in murine experimental asthma. Allergy. 66: 1193-200. PMID 21557750 DOI: 10.1111/J.1398-9995.2011.02614.X  0.741
2011 Gibb DR, Saleem SJ, Kang DJ, Subler MA, Conrad DH. ADAM10 overexpression shifts lympho- and myelopoiesis by dysregulating site 2/site 3 cleavage products of Notch. Journal of Immunology (Baltimore, Md. : 1950). 186: 4244-52. PMID 21368228 DOI: 10.4049/Jimmunol.1003318  0.749
2011 Gibb DR, Saleem SJ, Chaimowitz NS, Mathews J, Conrad DH. The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity. Molecular Immunology. 48: 1319-27. PMID 21236490 DOI: 10.1016/J.Molimm.2010.12.005  0.67
2010 Conrad DH, Gibb DR, Sturgill J. Regulation of the IgE response. F1000 Biology Reports. 2. PMID 20948818 DOI: 10.3410/B2-14  0.708
2010 Mathews JA, Gibb DR, Chen BH, Scherle P, Conrad DH. CD23 Sheddase A disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes. The Journal of Biological Chemistry. 285: 37531-41. PMID 20876574 DOI: 10.1074/Jbc.M110.141556  0.705
2010 Gibb DR, El Shikh M, Kang DJ, Rowe WJ, El Sayed R, Cichy J, Yagita H, Tew JG, Dempsey PJ, Crawford HC, Conrad DH. ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo. The Journal of Experimental Medicine. 207: 623-35. PMID 20156974 DOI: 10.1084/Jem.20091990  0.703
2010 Ochiai K, Singh H, Vu T, Funnell A, Gatto D, Brink R, Pearson R, Crossley M, Minamino K, Adachi T, Nagaoka K, Takahara K, Taki S, Inaba K, Touma M, ... ... Gibb DR, et al. B cell development (WS-030) Chairpersons: Daisuke Kitamura, David Gray International Immunology. 22. DOI: 10.1093/Intimm/Dxq187  0.744
2009 Le Gall SM, Bobé P, Reiss K, Horiuchi K, Niu XD, Lundell D, Gibb DR, Conrad D, Saftig P, Blobel CP. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha. Molecular Biology of the Cell. 20: 1785-94. PMID 19158376 DOI: 10.1091/Mbc.E08-11-1135  0.556
2009 Gibb D, Kang D, Allen J, Conrad D. ADAM-10 Overexpression Inhibits B cell Development and Promotes Myeloid-derived Suppressor Cell Granulopoesis Journal of Allergy and Clinical Immunology. 123: S92-S92. DOI: 10.1016/J.JACI.2008.12.330  0.602
2007 Conrad DH, Ford JW, Sturgill JL, Gibb DR. CD23: an overlooked regulator of allergic disease. Current Allergy and Asthma Reports. 7: 331-7. PMID 17697638 DOI: 10.1007/S11882-007-0050-Y  0.76
Show low-probability matches.